Global Routine Vaccination Coverage — 2017

VanderEnde, Kristin; Gacic-Dobo, Marta; Diallo, Mamadou Saliou; Conklin, Laura; Wallace, Aaron S.

doi:10.15585/mmwr.mm6745a2

Cited by 94 publications

(99 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Building on previous analyses ( 2 ) and using the World Health Organization (WHO) and United Nations Children’s Fund (UNICEF) global vaccination coverage estimates as of 2018, this report presents global, regional, and national vaccination coverage estimates and trends, including vaccination dropout rates. According to these estimates, global coverage with the first dose of diphtheria and tetanus toxoids and pertussis-containing vaccine (DTP1) remained relatively unchanged from 2010 (89%) to 2018 (90%).…”

mentioning

confidence: 99%

Global Routine Vaccination Coverage, 2018

Peck¹,

Gacic-Dobo²,

Diallo³

et al. 2019

MMWR Morb. Mortal. Wkly. Rep.

Self Cite

166

129

View full text Add to dashboard Cite

mentioning

confidence: 99%

Global Routine Vaccination Coverage, 2018

Peck¹,

Gacic-Dobo²,

Diallo³

et al. 2019

MMWR Morb. Mortal. Wkly. Rep.

Self Cite

166

129

View full text Add to dashboard Cite

“…Unfortunately, families often lose the card. Of the 10 countries with largest amount of unvaccinated children, 2 nine have had a national cross-sectional study under the Demographic and Health Surveys (DHS) program within the past six years (the one exception being Iraq). 3 These countries report low levels of diphtheria-tetanus-pertussis (DTP) dose 3 coverage, ranging from 34.5% in Angola and 35.5% in Nigeria to 71.5% in India (Table 1).…”

Section: Use For Parents and The Vaccineementioning

confidence: 99%

The use and significance of vaccination cards

Wagner

2019

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

Vaccination cards are useful health records that contain information about vaccination dates and dosage. This information is helpful for parents, vaccination providers, and public health researchers. However, as they currently are structured, many vaccination cards are very difficult to read by non-experts, like parents, and even by health-care providers. Many families also lose these vaccination cards; among the top 10 countries with the most unvaccinated children, the proportion of families who were able to find their vaccination cards and give them to researchers was low, ranging from 20.7% in the Democratic Republic of the Congo to 69.2% in South Africa. Moreover, some families report that not having a vaccination card during a vaccination visit resulted in them being unable to obtain a vaccine (8% in one study in Ethiopia and 16% in one study in Bangladesh). This commentary provides recommendations about how vaccination cards should be used by parents, health-care providers, and researchers, and comments on their continued relevance in an era with increased use of electronic registries.

show abstract

“…Generally, routine poliovirus immunization schedules involve three or more doses worldwide, but most Japanese adults received only two doses of tOPV in childhood according to the national immunization program in Japan. As such, they have not completed the typical polio vaccine series as de ned abroad [18].…”

Section: Discussionmentioning

confidence: 99%

Immunogenicity of Two-Dose Booster Immunization with Conventional Inactivated Polio Vaccine in Japanese Adults

Fukushima

Nakano

Shimizu

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: Most Japanese adults have been vaccinated twice in childhood with the Sabin oral polio vaccine as part of routine immunization schedules. Booster vaccination is recommended for Japanese travelers to polio-endemic or high-risk countries. This study assessed the immunogenicity of a two-dose booster regimen of conventional inactivated polio vaccine (cIPV) in Japanese adults.Methods: Healthy Japanese adults aged 20 years or older received two doses of standalone cIPV derived from virulent strains (Imovax Polio®). Serum samples were obtained before the booster vaccination and 4–6 weeks after each vaccination. Immunogenicity was evaluated by measuring serum neutralization titers against type 1, 2, and 3 poliovirus strains using a microneutralization assay. Results: The subjects were 61 healthy Japanese adults (26 men and 35 women) with mean ± standard deviation age of 35.8 ± 8.0 years. The seropositivity rates (i.e., percentage of subjects with anti-polio antibody titers ≥1:8 ) before booster vaccination were 88.5%, 95.1%, and 52.5% for Sabin strains (type 1, 2, and 3, respectively); 72.1%, 93.4%, and 31.1% for virulent poliovirus strains (type1: Mahoney strain; type 2: MEF-1 strain; and type 3: Saukett strain, respectively); and 93.4%, 93.4%, 93.4% and 88.5% for type 2 vaccine-derived poliovirus strains (SV3128, SV3130, 11196, and 11198, respectively). After one dose of cIPV, all seropositivity rates increased to 98.4%–100.0%. After two doses of cIPV, seropositivity rates reached 100% for all strains. cIPV was well tolerated, with no safety concerns. Conclusion: Booster vaccination with standalone cIPV induced a robust immune response in Japanese adults. Trial registration: UMIN, UMIN000013551. Registered 28 March 2014 - Retrospectively registered, https://upload.umin.ac.jp/cgi-bin/ctr/ctr_view_reg.cgi?recptno=R000015830

show abstract

Global Routine Vaccination Coverage — 2017

Cited by 94 publications

References 5 publications

Global Routine Vaccination Coverage, 2018

Global Routine Vaccination Coverage, 2018

The use and significance of vaccination cards

Immunogenicity of Two-Dose Booster Immunization with Conventional Inactivated Polio Vaccine in Japanese Adults

Contact Info

Product

Resources

About